CCTG PR21: A randomized phase II study of [177lu]lu-PSMA-617 verus docetaxel in patients with metastatic castration-resistant prostate cancer and PSMA-positive disease (NCT04663997) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chi, Kim N
  • Saad, Fred
  • Parulekar, Wendy R
  • Emmenegger, Urban
  • Hotte, Sebastien
  • Pouliot, Frederic
  • Bauman, Glenn
  • Zukotynski, Katherine
  • Peacock, Stuart
  • Wyatt, Alexander William
  • Beauregard, Jean-Mathieu
  • Lee, Justin
  • Uribe, Carlos
  • Dellar, Conor
  • Ding, Keyue
  • Benard, Francois

publication date

  • June 1, 2022